Website of the Department of Health
Please note that this website has a UK government access keys system.
Page menu
Home
- Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI)
- Advisory Committee on Clinical Excellence Awards (ACCEA)
- Advisory Committee on Dangerous Pathogens (ACDP)
- Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO)
- Advisory Group on Hepatitis (AGH)
- Committee on the Medical Effects of Air Pollutants (COMEAP)
- Expert Advisory Group on AIDS (EAGA)
- Genetics and Insurance Committee (GAIC)
- Gene Therapy Advisory Committee (GTAC)
- Joint Committee on Vaccination and Immunisation (JCVI)
- Ministerial Medical Technology Strategy Group (MMTSG)
- National Blood Transfusion Committee (NBTC)
- National Clinical Audit Advisory Group (NCAAG)
- National Expert Panel on New and Emerging Infections (NEPNEI)
- Patient Information Advisory Group (PIAG)
- Scientific Pandemic Influenza Advisory Committee (SPI)
- Scientific Committee on Tobacco and Health (SCOTH)
- Standing Commission on Carers (SCOC)
- UK Stem Cell Initiative (UKSCI)
- Archive
- Advanced search
- Search results
- Help
- RSS Library
- Terms and conditions
- Site map
You are here:
Ministerial Medical Technology Strategy Group (MMTSG)
Ministerial Medical Technology Strategy Group (MMTSG)
The MMTSG has been established in accordance with the recommendation of the Healthcare Industries Task Force (HITF) Strategic Implementation Group (SIG). The Group will take forward SIG recommendations, NSR Innovation agenda for medical technology and provides a strategic forum for joint discussion of other issues of importance.
Links
Post HITF Strategic Implementation Group (SIG)
SIG was established for a period of two years to oversee HITF implementation. The main area of discussion concerned balancing NHS investment in new medical technologies with the need to secure best value for money. SIG published its report in March 2007.
Bioscience and Health Technology Database
'Strength and Opportunity : The landscape of the medical technology, medical biotechnology and industrial biotechnology enterprises in the UK' was launched on 10 December 2009. The report, the first of an annual series, presents a picture of the real strength in these sectors across the UK. see pdf file for full details.
A commentary on the report and background on the Bioscience and Health Technology Database can be found on the BIS website.
Mailbox
Healthcare Industries Task Force (HITF) report and background
HITF came about because of the healthcare industries' wish to develop a strategic dialogue with Government. Launched in October 2003, it was a joint year-long initiative which addressed a number of issues of common interest and agree solutions or improvements that would bring benefits for patients, the NHS, the national economy and industry. Lord Warner, the then Health Minister, responsible for medical devices industry sponsorship, co-chaired the Task Force with Sir Chris O'Donnell, CE of Smith & Nephew.
The areas of focus were market access, R&D and the industrial base, regulatory issues and international trade. The central themes which emerged were how to stimulate innovation in the NHS and industry and how to increase adoption of new useful medical technologies.
Additional links
Global links
Access keys
- Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI)
- Scientific Committee on Tobacco and Health (SCOTH)
- Joint Committee on Vaccination and Immunisation (JCVI)
- Advisory Committee on Dangerous Pathogens (ACDP)
- Advisory Committee on Clinical Excellence Awards (ACCEA)
- Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI)
